久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

日本榮研化學株社會 Eiken Chemical 
擁有70年歷史的日本榮研化學株社會社是日本東京證券交易所一部上市公司，主要從事體外診斷試劑盒、醫(yī)療器械和基因檢測制品的研發(fā)、生產(chǎn)、銷售。是日本該領(lǐng)域最大，也是全球領(lǐng)先的企業(yè)之一。
由榮研化學株社會社全資建立的榮研生物科技（上海）有限公司集研發(fā)中心、生產(chǎn)基地為一體、于2006年11月在上海張江高科技園區(qū)正式啟動運營。

北京藍譜生物科技有限公司是經(jīng)正式授權(quán)的日本榮研化學株式會社LAMP法相關(guān)產(chǎn)品在中國(包括港澳)地區(qū)的總經(jīng)銷代理企業(yè)，是經(jīng)國家相關(guān)部門批準注冊的企業(yè)。主營LAMP（環(huán)介導等溫擴增法）儀器及試劑，以及相關(guān)咨詢合作業(yè)務(wù)，公司總部位于北京市海淀區(qū)中關(guān)村南大街10號銀海大廈南315室，上海辦事處位于上海市浦東新區(qū)哈雷路1058號（榮研生物科技（中國）有限公司內(nèi)4F）

EIKEN CHEMICAL CO., LTD., from its foundation in 1939, has been committed to contributing to public health and the prevention of epidemics. In 1949, we became the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations.

In addition to microbiological diagnosis, we have played an active role in medical progress and public health through the development of clinical diagnostic aids vital to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers.

In 1998, EIKEN CHEMICAL developed an innovative nucleic acid amplification method, definite “LAMP” (Loop-mediated Isothermal Amplification).

With its advantages over conventional methods, it is inevitable that the LAMP method will be applied extensively across a variety of fields due to its outstanding characteristics as an innovative genetic testing procedure.

In September, 2004, EIKEN CHEMICAL established EIKEN SHANGHAI CO., LTD. in China, and in April, 2007, merged EIKEN KIZAI CO., LTD. which was a previously subsidiary. We will expand our business and utilize our financial resources effectively.

Clinical diagnosis is expected to grow in importance as a result of rising public demand for healthier living, and the prevention and early diagnosis of lifestyle-related diseases.

EIKEN CHEMICAL has established itself as a leader in the clinical diagnostics market, and will maintain its commitment to public health through the development of products and technologies that fill needs at the cutting edge of contemporary medicine.